Eli Lilly and Company (NYSE:LLY) is among the most profitable healthcare stocks to buy. On January 26, Srikripa Devarakonda, an analyst at Truist Financial,
Bullish
Is Bullish Earnings Sentiment With Modest Revenue Growth Altering The Investment Case For Allstate (ALL)?
In late January 2026, analysts reiterated positive views on Allstate as the market looked back on expectations for higher year-over-year earnings and revenue for
Plug Power Stock: A Deep-Value Investment or a Dangerous Holding?
Plug Power has an ambitious goal of creating a hydrogen ecosystem that will be a zero-carbon energy source. If successful, the company could help
CSX Corporation stock: Is Wall Street bullish or bearish?
With a market cap of $70.5 billion, CSX Corporation (CSX) is a leading rail-based freight transportation company operating across the United States and Canada,
3 growth stocks with explosive earnings potential for 2026
Three growth stocks analysts favor for 2026, with earnings catalysts, Wall Street views, recent performance, and key risks across Amazon, Apple, and Nvidia.
Prediction: Nvidia stock will soar to this price in 2026 as the AI boom expands from data centers to robotaxis
Nvidia shares could charge higher as artificial intelligence (AI) spending increases across data centers and autonomous vehicles.
Powell Industries: Profitability And Growth Justify The Premium – Still Bullish
Powell Industries, Inc. reports $1.1B revenue and a $1.3B backlog with 28.2% ROE and no debt in FY25. Check out why POWL stock is
RBC Bullish on Marvell’s (MRVL) Data Center and AI Chip Growth
Marvell Technology, Inc. (NASDAQ:MRVL) ranks among the most promising QQQ stocks according to hedge funds. On January 14, RBC Capital launched coverage of Marvell
Microsoft’s earnings bust drags software stocks into a bear market and tanks major indexes
Shares of Microsoft plunged 12% and software stocks hit a bear market. The S&P 500 edged back from 7,000 as AI spending fears were
Why Piper Sandler thinks UnitedHealth stock is the top insurer to buy now
Piper Sandler analyst Jessica Tassan remains bullish on UnitedHealth (UNH) stock, although she lowered her price target on shares. This comes after news that